The 340B Program enables covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services. …

A person receiving 340B drugs must be a patient of the covered entity. However, unique circumstances may be considered to decide if an individual fits the definition of patient (PDF - …

OPA’s website provides information and other resources to educate and inform the variety of 340B Drug Pricing Program stakeholders about the program.

To purchase drugs at the 340B price, covered entities must continue to meet the requirements of the 340B Drug Pricing Program.

Under section 340B(a) of the Public Health Service Act (PHSA), the 340B ceiling price is calculated by subtracting the unit rebate amount (URA) from the average manufacturer price …

The 340B registration and pricing databases are known as the 340B Office of Pharmacy Affairs Information System (340B OPAIS). Authorized users of 340B OPAIS must have a user …

Covered entities and their partners may need to analyze drugs on the OOPD list to decide which orphan drugs to exclude from the 340B Program and the appropriate time frame. We …

In calendar year 2023, 340B covered entities purchased $66.3 billion in covered outpatient drugs under the 340B Program. The program enables safety-net providers to stretch scarce federal …

Sec. 340B PUBLIC HEALTH SERVICE ACT LIMITATION ON PRICES OF DRUGS PURCHASED BY COVERED ENTITIES (a) REQUIREMENTS FOR AGREEMENT WITH …

Contact the 340B Prime Vendor www.340bpvp.com. 1-888-340-2787. 8AM-5PM CT Mon-Fri. [email protected]. You are entering an official US Government computer …